CAS 18462-27-6

Fórmula: C22H30O5

InChI: InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14+,15+,17+,19-,20+,21+,22+/m1/s1

Clave InChI: VHRSUDSXCMQTMA-DZDRLISQSA-N

SMILES: C[C@@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O

Methylprednisolone EP Impurity H (6-β-Methyl Prednisolone)

CAS: 18462-27-6

Fórmula: C₂₂H₃₀O₅

Forma y color: White To Off-White Solid

Peso molecular: 374.48

Ref: 4Z-P-11149

6β-Methylprednisolone-d3

Producto controlado

CAS: 18462-27-6

Fórmula: C₂₂D₃H₂₇O₅

Forma y color: Neat

Peso molecular: 377.489

Ref: TR-M326937

Methylprednisolone EP impurity H

CAS: 18462-27-6

Fórmula: C₂₂H₃₀O₅

Peso molecular: 374.48

Ref: ST-EA-CP-M14008

6β-Methylprednisolone

Producto controlado

CAS: 18462-27-6

6b-Methylprednisolone is a corticosteroid that has been used in the treatment of bowel diseases and inflammatory disorders. It is active orally and can be given as a single dose. Methylprednisolone binds to glucocorticoid receptors which are found on various cells, including those in the immune system. It inhibits the production of proinflammatory cytokines by inhibiting phospholipase A2, an enzyme involved in the synthesis of arachidonic acid from membrane phospholipids. 6b-Methylprednisolone also prevents the expression of inflammatory genes by inhibiting transcription factors such as NF-κB, AP1, and AP2. 6b-Methylprednisolone has been shown to have immunosuppressive activity with reduced incidence of rejection after kidney transplantation or erythropoietin therapy for patients with chronic kidney disease. 6b-Methylprednisolone has also been shown

Fórmula: C₂₂H₃₀O₅

Pureza: Min. 95%

Forma y color: Powder

Peso molecular: 374.47 g/mol

Ref: 3D-FM165427